Andy Wallen

Andy Wallen has a strong background in regulatory operations and publishing in the pharmaceutical industry. Andy recently served as the Director of Regulatory Operations & Publishing at Mersana Therapeutics. Prior to that, they were the Senior Director of Regulatory Operations at Novo Nordisk, where they worked from October 2022 to February 2023. From 2019 to 2022, they held the position of Senior Director of Regulatory Operations at FORMA Therapeutics, Inc. Andy also has experience as the Director of Regulatory Operations at TESARO, Inc. from April 2017 to August 2019. Before that, they held various roles at Vertex Pharmaceuticals, starting as a Senior Associate and working their way up to Director. Andy'scareer in regulatory affairs began at Genzyme as a Senior Associate from September 2006 to July 2008. Andy also worked in regulatory affairs at Acambis from 2002 to 2007.

Andy Wallen earned a Bachelor of Arts degree in English from the University of Connecticut, completing their education from 1988 to 1992. Andy also obtained a BS degree in Exercise Physiology from the State University of New York Cortland. Additionally, they have completed various certifications including Group 2: GMP Teams (GMP) from the CITI Program and Microsoft Planner Essential Training, SharePoint Online Essential Training: The Basics, and 2-Minute Tips for Senior Leaders from LinkedIn.